Oric Pharmaceuticals Stock

oricpharma.comHealthcare / BioTech & PharmaFounded: 2014Funding to Date: $173MM

ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer.

Register To Buy and Sell Shares

For more details on financing and valuation for Oric Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Oric Pharmaceuticals’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Oric Pharmaceuticals.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Jacob Chacko MD
Chief Executive Officer & Board Member
Charles Sawyers MD
Dominic Piscitelli
Chief Financial Officer
Matthew Panuwat
Chief Business Officer
Lori Friedman Ph.D
Chief Scientific Officer
Richard Heyman Ph.D
Co-Founder, Chairman & Board Member
Scott Lowe Ph.D

Board Members

Leo Guthart
Laurence Lasky Ph.D
Richard Scheller Ph.D
Carl Gordon Ph.D
Richard Heyman Ph.D
Peter Svennilson
The Column Group
Jacob Chacko MD

Frequently Asked Questions About Oric Pharmaceuticals’ Stock

Can you buy Oric Pharmaceuticals’ stock?
Oric Pharmaceuticals is not publicly traded on NYSE or NASDAQ in the U.S. To buy Oric Pharmaceuticals’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Oric Pharmaceuticals’ stock?
Yes, you can sell stock of a private company like Oric Pharmaceuticals. Forge can help you sell your Oric Pharmaceuticals stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Oric Pharmaceuticals’ stock price?
Oric Pharmaceuticals is a privately held company and therefore does not have a public stock price. However, you may access Oric Pharmaceuticals’ private market stock price with Forge Data.
What is Oric Pharmaceuticals’ stock ticker symbol?
Oric Pharmaceuticals does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Xconomy: ORIC Pharma Gets $120M in IPO to Advance Drug-Resistant Cancer Therapies
ORIC Pharmaceuticals followed in the footsteps of the other biotechs that have managed to go public this month, selling more shares than it expected for a
ORIC Pharmaceuticals Appoints Dominic Piscitelli as Chief Financial Officer
/PRNewswire/ -- ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on developing cancer treatments that address mechanisms of...
ORIC Pharmaceuticals : Announces Completion of $55 Million Mezzanine Financing to Advance Pipeline of Novel Therapies Targeting Cancer Resistance
Updated on: Apr 14, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.